Concepedia

Ronghua Yang

RY

Statistics

Publications

35

Citations

2.2K

H-Index

23

Active since

2006

Affiliations

First People's Hospital of Foshan(Current)

Teva Pharmaceuticals (United States)

Sun Yat-sen University

The First Affiliated Hospital, Sun Yat-sen University

Thomas Jefferson University

Ronghua Yang is an author at First People's Hospital of Foshan specializing in clinical pharmacology, pharmacotherapy, and pharmacology.

Publications per year

2006–2022

35

Publications

35

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Marcelo E. Bigal, David W. Dodick, Alan M. Rapoport et al. · The Lancet Neurology · 2015 · 285 citations

Medicine, Neurology, Preventive Medicine +8

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Marcelo E. Bigal, Lars Edvinsson, Alan M. Rapoport et al. · The Lancet Neurology · 2015 · 260 citations

Medicine, Neurology, Preventive Medicine +9

Conditioned Medium from Hypoxic Bone Marrow-Derived Mesenchymal Stem Cells Enhances Wound Healing in Mice

Lei Chen, Yingbin Xu, Jingling Zhao et al. · PLoS ONE · 2014 · 259 citations · Full text

Life Sciences, Bioengineering, Cell Biology +15

Wnt and Notch signaling pathway involved in wound healing by targeting c-Myc and Hes1 separately

Yan Shi, Bin Shu, Ronghua Yang et al. · Stem Cell Research & Therapy · 2015 · 180 citations · Full text

Life Sciences, Biomedical Sciences, Cell Biology +15

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

Stephen D. Silberstein, Joshua M. Cohen, Michael J. Seminerio et al. · The Journal of Headache and Pain · 2020 · 129 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

1–5 of 35